Matthew Buten
CIK: 0001898799
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Biohaven Ltd.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Feb 27, 2026BHVN
Biohaven Ltd.
Award(A)DirectStock Options (Right to buy)
175K shares- - Jan 5, 2026BHVN
Biohaven Ltd.
Tax Payment(F)Direct2.6K shares at avg. $9.93$26K - Jan 5, 2026BHVN
Biohaven Ltd.
Exercise(M)Direct4.3K shares- - Jan 5, 2025BHVN
Biohaven Ltd.
Award(A)DirectRestricted Share Unit Award
17K shares- - Jan 5, 2025BHVN
Biohaven Ltd.
Tax Payment(F)Direct2.6K shares at avg. $38.64$99K - Jan 5, 2025BHVN
Biohaven Ltd.
Exercise(M)Direct4.3K shares- - Jan 5, 2025BHVN
Biohaven Ltd.
Award(A)DirectStock Options (Right to buy)
104K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 27, 2026 | BHVN Biohaven Ltd. | Award(A) Stock Options (Right to buy) | 175,000 | - | - | Direct |
| Jan 5, 2026 | BHVN Biohaven Ltd. | Tax Payment(F) | 2,594 | $9.93 | $25,758 | Direct |
| Jan 5, 2026 | BHVN Biohaven Ltd. | Exercise(M) | 4,250 | - | $0 | Direct |
| Jan 5, 2025 | BHVN Biohaven Ltd. | Award(A) Restricted Share Unit Award | 17,000 | - | - | Direct |
| Jan 5, 2025 | BHVN Biohaven Ltd. | Tax Payment(F) | 2,561 | $38.64 | $98,957 | Direct |
| Jan 5, 2025 | BHVN Biohaven Ltd. | Exercise(M) | 4,250 | - | $0 | Direct |
| Jan 5, 2025 | BHVN Biohaven Ltd. | Award(A) Stock Options (Right to buy) | 104,000 | - | - | Direct |
1-7 of 7 transactions
About Buten Matthew
Buten Matthew (SEC CIK 0001898799) files insider reports with the SEC as Chief Financial Officer of Biohaven Ltd. (BHVN).
Signal8 holds 3 ownership filings by Buten Matthew, all Form 4s, filed between Jan 7, 2025 and Mar 3, 2026. Those filings report 7 transactions, from Jan 5, 2025 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Buten Matthew's filings is in NEW HAVEN, CT.
Recent filings by Buten Matthew
- Feb 27, 2026: Grant or award of BHVN derivative securities (Form 4, code A).
- Jan 5, 2026: Tax withholding of BHVN shares (Form 4, code F).
- Jan 5, 2026: Option exercise of BHVN shares (Form 4, code M).
- Jan 5, 2025: Grant or award of BHVN derivative securities (Form 4, code A).
- Jan 5, 2025: Tax withholding of BHVN shares (Form 4, code F).
Other insiders filing for Biohaven Ltd. (BHVN)
- Gentile Kimberly, SVP, Clinical Operations
- Yetimoglu John, Director
- Volles Warren Karl, Chief Legal Officer
- Mehta Kishan, Director
- Bailey Gregory, Director
- Heffernan Michael Thomas, Director